1. Hsp47 acts as a bridge between NLRP3 inflammasome and hepatic stellate cells activation in arsenic-induced liver fibrosis.
- Author
-
Yuan, Weizhuo, Qiu, Tianming, Yao, Xiaofeng, Wu, Chenbing, Shi, Yan, Wang, Ningning, Zhang, Jingyuan, Jiang, Liping, Liu, Xiaofang, Yang, Guang, Bai, Jie, and Sun, Xiance
- Subjects
- *
HEPATIC fibrosis , *LIVER cells , *NLRP3 protein , *INFLAMMASOMES , *AMINO acid sequence - Abstract
The activation of hepatic stellate cells (HSCs) is a key event during the progression of liver fibrosis (LF). We have previously indicated that NLRP3 inflammasome plays a crucial role in arsenic-induced HSCs activation. However, the mechanism of cascade responses between NLRP3 inflammasome and HSCs activation is unclear. Here, we showed that the transcription and protein level of Hsp47 was upregulated after 4 μM arsenic treatment, both in vivo and in vitro. Additionally, arsenic-induced HSCs activation was remarkably alleviated by the interference of Hsp47. Furthermore, blockage of NLRP3 significantly mitigated the activation of the NLRP3 inflammasome and decreased the expression of Hsp47, thereby attenuating the arsenic-induced HSCs activation. However, the ablation of Hsp47 did not affect the activation of the NLRP3 inflammasome. Notably, the protein-protein interaction between NLRP3 and Hsp47 was observed both in vivo and in vitro , and the target amino acid sequences were further identified. In summary, the present study indicated that NaAsO 2 induced HSCs activation via the NLRP3 inflammasome-Hsp47 pathway. These findings provide direct evidence that Hsp47 may be a potential therapeutic target for arsenic-induced LF. [Display omitted] • Hsp47 plays a critical role in HSCs activation and iAs-induced liver fibrosis. • iAs treatment upregulates Hsp47 via promoting NLRP3 inflammasome activation. • NLRP3 interacts with Hsp47 during the activation of HSCs by iAs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF